Financials

  • Market Capitalization 2 B
  • Employee 361
  • Founded 2016
  • CEO N/A
  • Website www.veratx.com
  • Headquarter Delaware, United States
  • FIGI BBG00Q72WYG3
  • Industry Biotecnología
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
-10.87
Relación precio/flujo de caja
7 992.14

Related tickers

#NombrePrecio24h %7d %1M %1A %CapitalizaciónÚltimos 7 días
1923
VRDN
Viridian Therapeutics, Inc. - Common Stock
18.30 USD-1.93%-4.34%-14.76%-18.49%2.07 B USD
1948
PHVS
Pharvaris N.V. - Ordinary Shares
30.89 USD-0.68%+1.28%-19.24%+41.70%2.01 B USD
1953
FTRE
Fortrea Holdings Inc. - Common Stock
21.00 USD+0.77%-4.55%+21.95%+121.99%2.00 B USD
1961
MLYS
Mineralys Therapeutics, Inc. - Common Stock
22.23 USD-4.88%-5.56%-21.00%-44.93%1.97 B USD

Noticias